Chemoinformaics analysis of ?-cryptoxanthin epoxide
Molecular Weight | 568.886 | nRot | 10 |
Heavy Atom Molecular Weight | 512.438 | nRig | 23 |
Exact Molecular Weight | 568.428 | nRing | 3 |
Solubility: LogS | -4.699 | nHRing | 1 |
Solubility: LogP | 6.215 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 40 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 105.744 |
nHD | 1 | BPOL | 57.9156 |
QED | 0.21 |
Synth | 4.953 |
Natural Product Likeliness | 2.133 |
NR-PPAR-gamma | 0.981 |
Lipinski | Rejected |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.012 |
CACO-2 | -5.32 |
MDCK | 0.0000139 |
BBB | 0.03 |
PPB | 1.02839 |
VDSS | 1.166 |
FU | 0.0540853 |
CYP1A2-inh | 0.421 |
CYP1A2-sub | 0.944 |
CYP2c19-inh | 0.867 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.925 |
CYP2c9-sub | 0.999 |
CYP2d6-inh | 0.957 |
CYP2d6-sub | 0.978 |
CYP3a4-inh | 0.971 |
CYP3a4-sub | 0.811 |
CL | 1.968 |
T12 | 0.027 |
hERG | 0.105 |
Ames | 0.091 |
ROA | 0.079 |
SkinSen | 0.361 |
Carcinogencity | 0.694 |
EI | 0.518 |
Respiratory | 0.879 |
NR-Aromatase | 0.697 |
Antiviral | Yes |
Prediction | 0.620637 |